Society for Immunotherapy of Cancer (SITC)
Mindon (Whalen) Laue possesses extensive experience in nonprofit management and development, currently serving as a Senior Development Manager at the Society for Immunotherapy of Cancer since February 2015. Previous roles include Development Manager and Development Coordinator at the same organization, alongside an Administrative Assistant position at Meaningful Day Services. Mindon's background includes a year as an Americorps VISTA with CASA Works, focusing on advocacy for abused and neglected children. Education credentials include a Master of Arts in Nonprofit Organizations from the University of Georgia and a Bachelor of Arts in Communications from the University of Louisville. Additional experience encompasses internships and coordination roles in community relations and research in various organizations.
This person is not in any teams
Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC has more than 2,000 members who represent 22 medical specialties in 42 countries around the world. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.